# NE1 INC.: Personalized Therapeutic Cancer Vaccine for Glioblastoma to Enhance Overall Survival and Prevent Recurrence

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | NE1 INC. |
| Location | NEW YORK, NY |
| Project | Personalized Therapeutic Cancer Vaccine for Glioblastoma to Enhance Overall Survival and Prevent Recurrence |
| Project number | 1R43CA306479-01 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $388,656 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-08 to 2027-08-31 |
| UEI | HH73JLLPTFD7 |

## Why this score
- Award of $388,656.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11253187). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.